Results 191 to 200 of about 156,448 (312)
Qing-Hui Li,1,2 Qiu-Yan Zhao,1 Wei-Jing Yang,1 Ai-Fang Jiang,2 Chun-E Ren,2 Yu-Han Meng2 1School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, 261021, People’s Republic of China; 2Center of Reproductive Medicine, Affiliated
Li QH +5 more
doaj
Ustekinumab resistance in individuals with ulcerative colitis is associated with an alteration of a subset of proinflammatory mucosal regulatory T cells. [PDF]
Briggs KC +14 more
europepmc +1 more source
Objective Methotrexate (MTX) is the first‐line therapy for juvenile idiopathic arthritis (JIA), but up to 40% of patients do not respond to it. Low inosine triphosphate pyrophosphatase (ITPA) activity has been associated with reduced clinical remission. We investigated the role and underlying mechanisms of ITPA in vitro. Methods ITPA enzymatic activity
Sofia Sindici Forgiarini +19 more
wiley +1 more source
Regulatory T Cells in Diabetic Wound Healing: A Comprehensive Review. [PDF]
Lin J +5 more
europepmc +1 more source
Objective Here we investigate the status of the adiponectin–PEPITEM pathway in early, treatment naive rheumatoid arthritis (RA) and psoriatic arthritis (PsA) and the therapeutic efficacy of PEPITEM administration in preclinical models. Methods Peripheral blood was isolated from patients with clinical suspect arthralgia and suspected inflammatory ...
Mussarat Wahid +34 more
wiley +1 more source
Treg-derived IFN-γ supports the differentiation of Th1-Treg in tumor immunity and autoimmunity. [PDF]
Kuratani A +5 more
europepmc +1 more source
Objective Rituximab, a CD20+ B cell depletion therapy, is frequently used to treat systemic lupus erythematosus (SLE). However, variability in patient response highlights the need for a deeper understanding of the underlying immune cell dynamics of B cell depletion and repopulation.
Haerin Jang +9 more
wiley +1 more source
Regulatory T cell dysfunction and exhaustion in uveitis: immunometabolic mechanisms, microenvironmental drivers, and emerging therapeutic strategies. [PDF]
Su X, Tan Q, Zheng L, Ding Z.
europepmc +1 more source
Objective Regeneration and expansion of Treg by low‐dose interleukin‐2 (IL‐2) therapy is considered a potential treatment strategy for a wide range of autoimmune diseases. To provide a pathophysiologically‐based rationale for low‐dose IL‐2 therapy, we investigated whether reversible defects in the Treg–IL‐2 axis emerge in inflammatory myopathies ...
Justus Ohmes +10 more
wiley +1 more source

